APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pentavalent Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pentavalent Vaccine Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchPentavalent Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pentavalent Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pentavalent Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pentavalent Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pentavalent Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pentavalent Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pentavalent Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pentavalent Vaccine include Bio Farma, Biological E. Ltd., Crucell, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Novartis AG and Serum Institute of India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pentavalent Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pentavalent Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pentavalent Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pentavalent Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pentavalent Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pentavalent Vaccine Market by Company

Bio Farma

Biological E. Ltd.

Crucell

Panacea Drugs Pvt. Ltd

Shantha Biotechnics

Novartis AG

Serum Institute of India

Pentavalent Vaccine Segment by Type

Lyophilized

Liquid

Pentavalent Vaccine Segment by Application

Hospital Pharmacy

Retail Pharmacy

E-commerce

Pentavalent Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pentavalent Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pentavalent Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pentavalent Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pentavalent Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pentavalent Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lyophilized Table 2. Major Company of Liquid Table 3. Global Pentavalent Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Pentavalent Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pentavalent Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pentavalent Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Pentavalent Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Pentavalent Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Pentavalent Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pentavalent Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pentavalent Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Pentavalent Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Pentavalent Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Pentavalent Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Pentavalent Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Pentavalent Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pentavalent Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Pentavalent Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Pentavalent Vaccine Industry Trends Table 25. Pentavalent Vaccine Industry Drivers Table 26. Pentavalent Vaccine Industry Opportunities and Challenges Table 27. Pentavalent Vaccine Industry Restraints Table 28. Global Pentavalent Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pentavalent Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Pentavalent Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Pentavalent Vaccine Sales Share by Company (2021-2026) Table 32. Global Pentavalent Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Pentavalent Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pentavalent Vaccine Major Company Production Sites and Headquarters Table 35. Global Pentavalent Vaccine Company, Product Type & Application Table 36. Global Pentavalent Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pentavalent Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pentavalent Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pentavalent Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Pentavalent Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pentavalent Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pentavalent Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Pentavalent Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Pentavalent Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Pentavalent Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pentavalent Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pentavalent Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Pentavalent Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Pentavalent Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Pentavalent Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pentavalent Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pentavalent Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Pentavalent Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Pentavalent Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Pentavalent Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pentavalent Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pentavalent Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Pentavalent Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Pentavalent Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Pentavalent Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Pentavalent Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Pentavalent Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pentavalent Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Pentavalent Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Bio Farma Company Information Table 72. Bio Farma Business Overview Table 73. Bio Farma Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Bio Farma Pentavalent Vaccine Product Portfolio Table 75. Bio Farma Recent Development Table 76. Biological E. Ltd. Company Information Table 77. Biological E. Ltd. Business Overview Table 78. Biological E. Ltd. Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Biological E. Ltd. Pentavalent Vaccine Product Portfolio Table 80. Biological E. Ltd. Recent Development Table 81. Crucell Company Information Table 82. Crucell Business Overview Table 83. Crucell Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Crucell Pentavalent Vaccine Product Portfolio Table 85. Crucell Recent Development Table 86. Panacea Drugs Pvt. Ltd Company Information Table 87. Panacea Drugs Pvt. Ltd Business Overview Table 88. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolio Table 90. Panacea Drugs Pvt. Ltd Recent Development Table 91. Shantha Biotechnics Company Information Table 92. Shantha Biotechnics Business Overview Table 93. Shantha Biotechnics Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Shantha Biotechnics Pentavalent Vaccine Product Portfolio Table 95. Shantha Biotechnics Recent Development Table 96. Novartis AG Company Information Table 97. Novartis AG Business Overview Table 98. Novartis AG Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Novartis AG Pentavalent Vaccine Product Portfolio Table 100. Novartis AG Recent Development Table 101. Serum Institute of India Company Information Table 102. Serum Institute of India Business Overview Table 103. Serum Institute of India Pentavalent Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Serum Institute of India Pentavalent Vaccine Product Portfolio Table 105. Serum Institute of India Recent Development Table 106. North America Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 108. North America Pentavalent Vaccine Sales Market Share by Country (2021-2026) Table 109. North America Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Pentavalent Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. North America Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Pentavalent Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Pentavalent Vaccine Market Share by Country (2021-2026) Table 114. North America Pentavalent Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Pentavalent Vaccine Market Share Forecast by Country (2027-2032) Table 116. Europe Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 118. Europe Pentavalent Vaccine Sales Market Share by Country (2021-2026) Table 119. Europe Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Pentavalent Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Pentavalent Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Pentavalent Vaccine Market Share by Country (2021-2026) Table 124. Europe Pentavalent Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Pentavalent Vaccine Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Pentavalent Vaccine Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Pentavalent Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Pentavalent Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Pentavalent Vaccine Market Share by Country (2021-2026) Table 134. Asia-Pacific Pentavalent Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Pentavalent Vaccine Market Share Forecast by Country (2027-2032) Table 136. Latin America Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 138. Latin America Pentavalent Vaccine Sales Market Share by Country (2021-2026) Table 139. Latin America Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Pentavalent Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Pentavalent Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Pentavalent Vaccine Market Share by Country (2021-2026) Table 144. Latin America Pentavalent Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Pentavalent Vaccine Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Pentavalent Vaccine Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Pentavalent Vaccine Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Pentavalent Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Pentavalent Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Pentavalent Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Pentavalent Vaccine Market Share by Country (2021-2026) Table 154. Middle East and Africa Pentavalent Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Pentavalent Vaccine Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Pentavalent Vaccine Distributors List Table 159. Pentavalent Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Pentavalent Vaccine Image Figure 2. Global Pentavalent Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pentavalent Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pentavalent Vaccine Sales (2021-2032) & (k units) Figure 5. Lyophilized Image Figure 6. Global Lyophilized Sales YoY Growth (2021-2032) & (k units) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Pentavalent Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pentavalent Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Pentavalent Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Pentavalent Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Pentavalent Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pentavalent Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pentavalent Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pentavalent Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pentavalent Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pentavalent Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pentavalent Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pentavalent Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pentavalent Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 27. E-commerce Image Figure 28. Global E-commerce Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Pentavalent Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pentavalent Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Pentavalent Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Pentavalent Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Pentavalent Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pentavalent Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pentavalent Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pentavalent Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pentavalent Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pentavalent Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pentavalent Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pentavalent Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Pentavalent Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Pentavalent Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pentavalent Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pentavalent Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pentavalent Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Pentavalent Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pentavalent Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pentavalent Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pentavalent Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Pentavalent Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pentavalent Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pentavalent Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pentavalent Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Pentavalent Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pentavalent Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pentavalent Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pentavalent Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Pentavalent Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pentavalent Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pentavalent Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pentavalent Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pentavalent Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized
  • Liquid
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce
Companies covered
  • Bio Farma
  • Biological E. Ltd.
  • Crucell
  • Panacea Drugs Pvt. Ltd
  • Shantha Biotechnics
  • Novartis AG
  • Serum Institute of India

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pentavalent Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pentavalent Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pentavalent Vaccine Market by Type
  6. 1.3.1 Lyophilized
  7. 1.3.2 Liquid
  8. 1.4 Global Pentavalent Vaccine Market Size by Type
  9. 1.4.1 Global Pentavalent Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pentavalent Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pentavalent Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pentavalent Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pentavalent Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pentavalent Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pentavalent Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pentavalent Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pentavalent Vaccine Industry Trends
  2. 2.2 Pentavalent Vaccine Industry Drivers
  3. 2.3 Pentavalent Vaccine Industry Opportunities and Challenges
  4. 2.4 Pentavalent Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pentavalent Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pentavalent Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pentavalent Vaccine Price (2021-2026)
  4. 3.4 Global Pentavalent Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pentavalent Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pentavalent Vaccine Company, Product Type & Application
  7. 3.7 Global Pentavalent Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pentavalent Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pentavalent Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pentavalent Vaccine Tier 1, Tier 2, and Tier 3
4 Pentavalent Vaccine Regional Status and Outlook
  1. 4.1 Global Pentavalent Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pentavalent Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pentavalent Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pentavalent Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pentavalent Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pentavalent Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pentavalent Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pentavalent Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pentavalent Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pentavalent Vaccine by Application
  1. 5.1 Pentavalent Vaccine Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 E-commerce
  5. 5.2 Global Pentavalent Vaccine Market Size by Application
  6. 5.2.1 Global Pentavalent Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pentavalent Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pentavalent Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pentavalent Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pentavalent Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pentavalent Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pentavalent Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pentavalent Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bio Farma
  2. 6.1.1 Bio Farma Company Information
  3. 6.1.2 Bio Farma Business Overview
  4. 6.1.3 Bio Farma Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bio Farma Pentavalent Vaccine Product Portfolio
  6. 6.1.5 Bio Farma Recent Developments
  7. 6.2 Biological E. Ltd.
  8. 6.2.1 Biological E. Ltd. Company Information
  9. 6.2.2 Biological E. Ltd. Business Overview
  10. 6.2.3 Biological E. Ltd. Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biological E. Ltd. Pentavalent Vaccine Product Portfolio
  12. 6.2.5 Biological E. Ltd. Recent Developments
  13. 6.3 Crucell
  14. 6.3.1 Crucell Company Information
  15. 6.3.2 Crucell Business Overview
  16. 6.3.3 Crucell Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Crucell Pentavalent Vaccine Product Portfolio
  18. 6.3.5 Crucell Recent Developments
  19. 6.4 Panacea Drugs Pvt. Ltd
  20. 6.4.1 Panacea Drugs Pvt. Ltd Company Information
  21. 6.4.2 Panacea Drugs Pvt. Ltd Business Overview
  22. 6.4.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolio
  24. 6.4.5 Panacea Drugs Pvt. Ltd Recent Developments
  25. 6.5 Shantha Biotechnics
  26. 6.5.1 Shantha Biotechnics Company Information
  27. 6.5.2 Shantha Biotechnics Business Overview
  28. 6.5.3 Shantha Biotechnics Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shantha Biotechnics Pentavalent Vaccine Product Portfolio
  30. 6.5.5 Shantha Biotechnics Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Pentavalent Vaccine Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Serum Institute of India
  38. 6.7.1 Serum Institute of India Company Information
  39. 6.7.2 Serum Institute of India Business Overview
  40. 6.7.3 Serum Institute of India Pentavalent Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Serum Institute of India Pentavalent Vaccine Product Portfolio
  42. 6.7.5 Serum Institute of India Recent Developments
7 North America by Country
  1. 7.1 North America Pentavalent Vaccine Sales by Country
  2. 7.1.1 North America Pentavalent Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pentavalent Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pentavalent Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pentavalent Vaccine Market Size by Country
  6. 7.2.1 North America Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pentavalent Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pentavalent Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pentavalent Vaccine Sales by Country
  2. 8.1.1 Europe Pentavalent Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pentavalent Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pentavalent Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pentavalent Vaccine Market Size by Country
  6. 8.2.1 Europe Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pentavalent Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pentavalent Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pentavalent Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pentavalent Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pentavalent Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pentavalent Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pentavalent Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pentavalent Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pentavalent Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pentavalent Vaccine Sales by Country
  2. 10.1.1 South America Pentavalent Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pentavalent Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pentavalent Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pentavalent Vaccine Market Size by Country
  6. 10.2.1 South America Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pentavalent Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pentavalent Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pentavalent Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pentavalent Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pentavalent Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pentavalent Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pentavalent Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pentavalent Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pentavalent Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pentavalent Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pentavalent Vaccine Value Chain Analysis
  2. 12.1.1 Pentavalent Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pentavalent Vaccine Production Mode & Process
  7. 12.2 Pentavalent Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pentavalent Vaccine Distributors
  10. 12.2.3 Pentavalent Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst